Moffitt Cancer Center Appoints New Director of Robotics Program

April 01, 2016

TAMPA, Fla. (April 1, 2016)Moffitt Cancer Center is a leader in robotics, operating on the highest number of cancer patients in Florida. Now this program has a new leader. Dr. Wade Sexton, senior member in the department of Genitourinary Oncology, has been appointed the director of Robotics. 

Since June 2008, the Moffitt Institute for Robotic Cancer Surgery has grown from one robotic system and two surgeons to two robots and 18 surgeons performing nearly 700 robotic surgeries in 2015. Dr. Julio Pow-Sang, program leader of Genitourinary Oncology, established the program, which initially focused on genitourinary and lung cancer patients. Today, robotic surgeries span prostate, bladder, gastrointestinal, gynecologic, endocrine, head & neck, lung and skin cancers. 

For patients, robotic surgery means shorter recovery times, fewer complications and smaller scars. Ultimately, this leads to a higher quality of life during recovery and better patient outcomes. 

“This is a great time for another surgeon to step in and take the lead,” said Pow-Sang. “Dr. Sexton is a great leader and will continue to take this program to new levels for the cancer center.” 

As part of its comprehensive approach to cancer care, Moffitt integrates minimally invasive and robotic-assisted surgery as an alternative to traditional surgery.  Moffitt uses the da Vinci Surgical System, which allows surgeons to operate through just a few small incisions. The da Vinci System features a magnified 3D high-definition vision system and tiny wristed instruments that bend and rotate far greater than the human hand. This enables the surgeon to operate with enhanced vision, precision and control. 

“There is tremendous evidence that robotic technology enhances our abilities as surgeons to offer cancer patients a minimally invasive surgical approach to helping them conquer their malignancies,” said Sexton. “As I step into the role as the new Director, my primary goal is to facilitate the application of the robotic platform for appropriately selected patients. I am both honored and excited for the opportunity to serve Moffitt Cancer Center, my colleagues and most importantly our patients in this capacity.” 

For more information on Moffitt’s Robotics Program, visit Moffitt.org or call 1-888-MOFFITT (1-888-663-3488). 

About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. One of the three largest cancer centers in the United States based on patient volume, the Tampa-based facility is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2 million square feet to research and patient care. With more than 5,000 team members, Moffitt has an economic impact in the state of $1.9 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.

###